Next-Generation Immunotherapy: Combining Virus-Specific T Cells with Other Immuno-Oncology Technologies to Treat Solid Tumors
Trending in Cancer Research: Automated Cell Identification, Unique Culture Solutions, Nanobody Development and More
Leukemia patients with certain gene regulation patterns may be less likely to respond to CAR T therapy
GammaDelta Therapeutics initiates first-in-human Phase 1 trial of GDX012 for the treatment of acute myeloid leukemia
